Article ISI
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER  (2023)

KEYNOTE-826: FINAL OVERALL SURVIVAL RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF PEMBROLIZUMAB plus CHEMOTHERAPY VS PLACEBO plus CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER

Monk, Bradley J.; Colombo, Nicoletta; Tewari, Krishnansu Sujata; Dubot, Coraline; Caceres, M. Valeria; Hasegawa, Kosei; Shapira-Frommer, Ronnie; Salman, Pamela; Yanez, Eduardo; Gumus, Mahmut; De Mendoza, Mivael Olivera Hurtado; Samouelian, Vanessa; Castonguay, Vincent; Arkhipov, Alexander; Tekin, Cumhur; et. al.